Integer Holdings Corporation

ITGR ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2012 FY2011 FY2010
Revenue $1.14B $1.08B $687.8M $663.9M $646.2M $568.8M $533.4M
Cost of Revenue $782.1M $737.8M $456.4M $444.6M $444.5M $388.5M $359.8M
Gross Profit $354.0M $337.7M $231.4M $219.3M $201.6M $180.4M $173.6M
Gross Margin 31.2% 31.4% 33.6% 33.0% 31.2% 31.7% 32.5%
Operating Expenses
Research & Development — — — — — — —
SG&A Expense $143.1M $136.4M $90.6M $88.1M $81.0M $72.5M $64.5M
Operating Income $125.6M $92.9M $75.7M $61.3M $25.8M $61.7M $69.0M
Operating Margin 11.1% 8.6% 11.0% 9.2% 4.0% 10.8% 12.9%
Interest Expense $64.0M $68.3M $4.3M $11.3M $18.1M $16.9M $18.5M
Pretax Income $49.3M $28.2M $76.6M $48.8M $6.7M $48.4M $49.3M
Income Tax Expense $-37.8M $3.3M $21.1M $12.6M $11.5M $15.3M $16.2M
Net Income $66.7M $6.0M $55.5M $36.3M $-4.8M $33.1M $33.1M
Net Margin 5.9% 0.6% 8.1% 5.5% -0.7% 5.8% 6.2%
EPS (Basic) $2.12 $0.19 $2.23 $1.51 $-0.20 $1.42 $1.44
EPS (Diluted) $2.08 $0.19 $2.14 $1.43 $-0.20 $1.40 $1.40
Shares Outstanding (Basic) 31.4M 30.8M 24.8M 24.0M 23.6M 23.3M 23.1M
Shares Outstanding (Diluted) 32.1M 31.0M 26.0M 25.3M 23.6M 23.6M 23.8M
Dividends Per Share — — — — — — —
← Newer Page 2 of 2 Older →